MALIN CORPORATION
Malin Corporation plc (“Malin”) is an Irish incorporated public limited company whose head office is in Dublin, Ireland with subsidiary offices in New Haven, Connecticut and Research Triangle, North Carolina, USA. Malin’s purpose is to create shareholder value through the selective long-term application of capital and operational expertise to private, pre-IPO, pre-trade sale operating businesses in dynamic and fast growing segments of the life sciences industry. Through its operational involvement, Malin works with its investee companies to enable them to reach the full potential of their value proposition and to achieve commercial success.
MALIN CORPORATION
Industry:
Biotechnology Life Science
Founded:
2014-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.malinplc.com
Total Employee:
1+
Status:
Active
Total Funding:
50 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-01-04 | Cilatus BioPharma | Cilatus BioPharma acquired by Malin Corporation | N/A |
| 2015-06-11 | Altan Pharma | Altan Pharma acquired by Malin Corporation | 34.5 M EUR |
Investors List
Ireland Strategic Investment Fund
Ireland Strategic Investment Fund investment in Venture Round - Malin Corporation
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-04-22 | Poseida Therapeutics | Malin Corporation investment in Series C - Poseida Therapeutics | 142 M USD |
| 2018-04-03 | Poseida Therapeutics | Malin Corporation investment in Series B - Poseida Therapeutics | 30.5 M USD |
| 2017-08-02 | Poseida Therapeutics | Malin Corporation investment in Series A - Poseida Therapeutics | 11.16 M USD |
| 2017-02-24 | Xenex | Malin Corporation investment in Venture Round - Xenex | 38 M USD |
| 2017-02-06 | Artizan Biosciences | Malin Corporation investment in Venture Round - Artizan Biosciences | N/A |
| 2017-01-16 | Wren Therapeutics | Malin Corporation investment in Funding Round - Wren Therapeutics | N/A |
| 2016-11-24 | Kymab | Malin Corporation investment in Series C - Kymab | 100 M USD |
| 2015-12-23 | Poseida Therapeutics | Malin Corporation investment in Series A - Poseida Therapeutics | 23 M USD |
| 2015-07-07 | 3D4Medical.com | Malin Corporation investment in Venture Round - 3D4Medical.com | 16.4 M USD |
| 2015-06-10 | Melinta Therapeutics | Malin Corporation investment in Post-IPO Equity - Melinta Therapeutics | 67 M USD |
Official Site Inspections
http://www.malinplc.com
- Host name: sirius.hosting.ie
- IP address: 79.170.242.5
- Location: Ireland
- Latitude: 53.3472
- Longitude: -6.2439
- Timezone: Europe/Dublin
